Diego Jiménez-Sánchez

Diego Jiménez-Sánchez

Auto-generated profile, based on publicly available information

Diego Jiménez-Sánchez

Electrophysiology Unit (V.C.-U., M.S.-D., D.J.-S., C.A.-A., P.V.-M., A.L.-R., D.G.-R., D.S.-O., C.P.-T., E.G.-I., J.T.-R., I.F.-L.), Cardiology Service, Hospital Electrophysiology Unit Puerta de Hierro, Madrid, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
VCVíctor Castro-Urda
Víctor Castro-Urda
MSMelodie Segura-Dominguez
Melodie Segura-Dominguez
DJDiego Jiménez-Sánchez
Diego Jiménez-Sánchez
CACristina Aguilera-Agudo
Cristina Aguilera-Agudo
PVPaula Vela-Martín
Paula Vela-Martín
IFIgnacio Fernández-Lozano
Ignacio Fernández-Lozano
BACKGROUND: Superior vena cava (SVC) has been considered a specific trigger in atrial fibrillation development. METHODS: We investigated the efficacy and safety of combining cryoballoon pulmonary vein isolation (PVI) with SVC ablation compared with PVI alone in 100 patients with paroxysmal or non–long-standing persistent atrial fibrillation. Patients were randomly assigned to either the PVI+SVC ablation group or the PVI-only group. Each patient was given a mobile device to record a daily ECG and detect atrial tachyarrhythmias. RESULTS: The primary end point, freedom from any atrial tachyarrhythmia recurrence between 91 and 365 days post-catheter ablation, did not significantly differ between the 2 groups (62.9% versus 72%; P =0.41). However, the PVI+SVC group exhibited higher rates of phrenic nerve paralysis (20.8% versus 6%; P =0.003) and transient sinus node injury (18.8% versus 0%; P =0.001) compared with the PVI-only group. The median burden of atrial tachyarrhythmia showed no significant difference ( P =0.91). CONCLUSIONS: The addition of SVC ablation to PVI did not enhance freedom from atrial tachyarrhythmia at 12 months, and it led to increased complications. These findings do not support the routine inclusion of SVC ablation in cryoballoon procedures for first-time catheter ablation in patients with paroxysmal or non–long-standing persistent atrial fibrillation.

6 December 2023 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
CPChinh Pham‐Trung
Chinh Pham‐Trung
DVDarwin Veloza‐Urrea
Darwin Veloza‐Urrea
MSMelodie Segura‐Domínguez
Melodie Segura‐Domínguez
YRYuleisy De la Rosa Rojas
Yuleisy De la Rosa Rojas
CACristina Aguilera‐Agudo
Cristina Aguilera‐Agudo
VCVíctor Castro‐Urda
Víctor Castro‐Urda

1 May 2021 in EP Europace
Verified
Journal Article
Open access
PDF file
APA Portoles-Hernandez
A Portoles-Hernandez
JTJ Toquero-Ramos
J Toquero-Ramos
SGS Garcia-Gomez
S Garcia-Gomez
VCV Castro-Urda
V Castro-Urda
EGE Garcia-Izquierdo
E Garcia-Izquierdo
IFI Fernandez-Lozano
I Fernandez-Lozano
Funding Acknowledgements: Type of funding sources: None. Introduction: The most frequent complications of atrial fibrillation (AF) ablation procedures are those related to the vascular access site, which are associated with increased morbidity and length of hospital stay. Purpose: To assess the safety and efficacy of venous access site closure with a suture-mediated vascular closure device (SVD), as well as the feasibility of early mobilization and same-day discharge protocol after AF ablation procedures. Methods: We conducted a retrospective analysis of all consecutive AF ablation patients in whom a SVD was employed to achieve hemostasis after each venous puncture. The ablation was performed under conscious sedation, using 7 to 12-F introducer sheaths. Anticoagulation was uninterrupted but for the last dose prior to the procedure. Intraprocedural heparin was not reversed. Groin ultrasound was performed in the first 10 patients with adequate SVD deployment. Three conditions were required for the same-day discharge protocol application: 1) uncomplicated procedure, 2) successful SVD deployment and 3) adequate recovery. Recovery followed a three-phase protocol: bed rest (two hours), sitting (one hour) and ambulation. Follow-up included phone call and clinical examination. Patients were offered contact to the electrophysiologist if needed. Results: 63 ablation procedures with SVD closure were performed from May 2019 to October 2020, with a total of 132 access sites analysed. Patient characteristics are shown in the table. The SVD was successfully deployed in 125 (94.7%) and hemostasis immediately achieved. In the remaining 5.3%, failure was attributed to a deficient technique, which missed to advance the knot to the vein. First 10 patients were ultrasound evaluated 24 hours later (no early discharge), showing total absence of complications. 35 subsequent patients (55.6% of the remaining 53) were discharged the same day without ultrasound control. The remaining 18 stayed overnight for reasons not related to the access site (hemodynamic surveillance, initiation of antiarrhythmic drugs or loss of phrenic capture), allowing in any case early mobilization (three hours after the procedure). Mean follow-up was 272 ± 160 days, with no adverse events recorded. Conclusion: SVD are safe and effective in achieving rapid hemostasis, making the early mobilization and same-day discharge protocol after AF ablation feasible in selected patients. Age 63 (57-71) Male 46 (73%) Body mass index (kg/m²) 27,5 (24,2-31,6) Previous anticoagulation- Vitamin K antagonist- Direct oral anticoagulation 50 (79,4%)14 (28%)36 (72%)

16 February 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
DJDiego Jiménez-Sánchez
Diego Jiménez-Sánchez
VCVíctor Castro-Urda
Víctor Castro-Urda
JTJorge Toquero-Ramos
Jorge Toquero-Ramos
MRMaría Alejandra Restrepo-Córdoba
María Alejandra Restrepo-Córdoba
MSManuel Sánchez-García
Manuel Sánchez-García
IFIgnacio Fernández-Lozano
Ignacio Fernández-Lozano

11 September 2023 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
DCDaniel de Castro
Daniel de Castro
JTJorge Toquero‐Ramos
Jorge Toquero‐Ramos
DJDiego Jiménez‐Sánchez
Diego Jiménez‐Sánchez
EGEusebio García‐Izquierdo
Eusebio García‐Izquierdo
VCVíctor Castro‐Urda
Víctor Castro‐Urda
IFIgnacio Fernández‐Lozano
Ignacio Fernández‐Lozano

21 February 2022 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
DCDaniel de Castro
Daniel de Castro
CACristina Aguilera‐Agudo
Cristina Aguilera‐Agudo
VCVíctor Castro‐Urda
Víctor Castro‐Urda
JTJorge Toquero
Jorge Toquero
DJDiego Jimenez‐Sanchez
Diego Jimenez‐Sanchez
EGEusebio García‐Izquierdo
Eusebio García‐Izquierdo